TRCT
NXTM

Tower Research Capital (TRC)’s NxStage Medical Inc. NXTM Stock Holding History

Tower Research Capital (TRC)’s Portfolio NXTM Stock Details NXTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-4,862
Closed -$136K – 4714
2018
Q3 		$136K Buy
+4,862
New +$137K 0.01% 1183
2018
Q2 		– Sell
-14,902
Closed -$370K – 4364
2018
Q1 		$370K Buy
14,902
+14,881
+70,862% +$362K 0.03% 611
2017
Q4 		$1K Sell
21
-3,344
-99% -$88.1K ﹤0.01% 3424
2017
Q3 		$93K Buy
+3,365
New +$89.7K 0.01% 1435
2017
Q1 		– Sell
-591
Closed -$15K – 4383
2016
Q4 		$15K Buy
+591
New +$14.6K ﹤0.01% 2392
2015
Q4 		– Sell
-7,994
Closed -$126K – 5399
2015
Q3 		$126K Buy
7,994
+5,911
+284% +$94.8K 0.01% 456
2015
Q2 		$29K Buy
2,083
+452
+28% +$7.66K ﹤0.01% 1801
2015
Q1 		$29K Buy
1,631
+832
+104% +$14.7K ﹤0.01% 1952
2014
Q4 		$14K Sell
799
-925
-54% -$14.9K ﹤0.01% 1878
2014
Q3 		$23K Buy
1,724
+1,476
+595% +$19.9K ﹤0.01% 2201
2014
Q2 		$4K Buy
248
+75
+43% +$979 ﹤0.01% 3074
2014
Q1 		$2K Sell
173
-125
-42% -$1.63K ﹤0.01% 3966
2013
Q4 		$3K Sell
298
-2,969
-91% -$33.7K ﹤0.01% 3906
2013
Q3 		$43K Sell
3,267
-655
-17% -$8.59K ﹤0.01% 2057
2013
Q2 		$56K Buy
+3,922
New +$49.3K ﹤0.01% 848

Other funds holding NXTM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TAL
TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
WCMNY
Westchester Capital Management (New York) Valhalla, New York $2.21B AUM 26.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Tower Research Capital (TRC)'s NXTM Position: Q4 2018 in Review

Tower Research Capital (TRC) sold out of NxStage Medical Inc. (NXTM) in Q4 2018, closing a stake of 4,862 shares — an estimated $136K sold.

Tower Research Capital (TRC) first reported a position in NXTM in Q2 2013 and held it in 15 quarters. The position peaked at $370K in Q1 2018. 172 funds tracked by Wall St. Rank hold NXTM as of Q4 2018.

  • Tower Research Capital (TRC) reported no remaining NxStage Medical Inc. position as of Q4 2018 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 4,862 NxStage Medical Inc. shares in Q4 2018, an estimated $136K.
  • Tower Research Capital (TRC) first reported a position in NxStage Medical Inc. in Q2 2013 and held it in 15 quarters.
  • Tower Research Capital (TRC)'s NxStage Medical Inc. position peaked at $370K in Q1 2018.
  • 172 funds tracked by Wall St. Rank held NxStage Medical Inc. as of Q4 2018.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2018, filed 14 Feb 2019.